Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Geko® T3 One vs Two Study

NCT: NCT07849257 · COMPLETED

NCT IDNCT07849257
StatusCOMPLETED
Start Date2025-12-09
Completion2026-01-16
SponsorKieron.Day (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this study to assess the haemodynamic effects of unilateral and bilateral geko® T3 stimulation on lower-limb circulation, measured by femoral artery and vein blood flow.

Frequently Asked Questions

What is Geko® T3 One vs Two Study?

Geko® T3 One vs Two Study is a clinical trial registered under NCT07849257. Current status: COMPLETED.

What is the status of NCT07849257?

The current status of NCT07849257 (Geko® T3 One vs Two Study) is: COMPLETED.

When did Geko® T3 One vs Two Study start?

Geko® T3 One vs Two Study started on 2025-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑